Taiwan FDA registration 1a65309d07c06afe10ee4eb99a42481a
Unified drug self-test pregnancy test series
TW: 統一藥品自我檢測驗孕系列
Taiwan·Risk Class 2·Formosa Biomedical Technology Co., Ltd. Yilan Factory;; Unipharmacy Co., Ltd·Registered Jan 15, 2010 – Jan 10, 2027ActiveRegistration details
- Analysis ID
- 1a65309d07c06afe10ee4eb99a42481a
- Customs Code
- DHY00500302401
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PRESIDENT PHARMACEUTICAL CORPORATION
Product details
- Intended Use
- Human chorionic gonadotropin (HCG) was detected in urine using rapid immunochromatography.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic
Dates and status
- Registration Date
- Jan 15, 2010
- Expiry Date
- Jan 10, 2027
About this record
Access comprehensive regulatory information for Unified drug self-test pregnancy test series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1a65309d07c06afe10ee4eb99a42481a and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory;; Unipharmacy Co., Ltd. The authorized representative in Taiwan is PRESIDENT PHARMACEUTICAL CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices